Finance Watch: Ten IPOs So Far In 2024, But Returns To Date Are Subpar
Surrozen Raises Up To $192.5m In Private Placement
Public Company Edition: This year’s newly public companies are trading an average of 9.7% below their IPO prices, including the two most recent debuts, Boundless Bio and Contineum. Also, Nkarta, Praxis and Nurix grossed $240m, $200m and $175m, respectively, in follow-on offerings.
